Surbhi Singh

Surbhi Singh

Auto-generated profile, based on publicly available information

Surbhi Singh

Department of Anatomy, Institute of Medical Sciences Banaras, Hindu University, Varanasi, U.P, 221005, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2025 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
SMShivani Mishra
Shivani Mishra
SSSurbhi Singh
Surbhi Singh
Ashish AshishAshish Ashish
Ashish Ashish
SRSangeeta Rai
Sangeeta Rai
RSRoyana Singh
Royana Singh

1 January 2024 in Eurasian Journal of Medical Advances
Verified
Journal Article
Closed access
SSSaumya Singh
Saumya Singh
AAAshish Anjankar
Ashish Anjankar
SSSurbhi Singh
Surbhi Singh
RSRoyana Singh
Royana Singh
Objectives: Wilson disease is an autosomal recessive copper balance disorder that causes liver damage and neurological disturbances to varying degrees. ATP7B protein, a hepatic copper-transporting protein, which is encoded by the defective gene ATP7B, is essential to human copper metabolism. A molecular docking technique has been employed to explore the potential of natural compounds targeting ATP7B protein as therapeutic agents for Wilson's disease. Methods: Neuroprotective natural compounds were screened based on the Lipinski Rule of 5, well-established criteria for drug-likeness. Molecular docking was performed using AutoDock 4, and the resulting complex structures were visualized and analyzed with the Biovia Discovery Studio 2020 visualizer. Subsequently, a detailed docking analysis of the selected natural compounds was conducted to identify potential lead compounds with high binding affinities to ATP7B protein. Docking of known drugs were also performed with ATP7B protein to compare the binding energies of the known drugs with top 5 selected natural compounds. Results: Among all the docked compounds, the top five natural compounds, namely Disogenin, Hecogenin, Withanolides, Berberine, and Anaferine. Their binding energies ranged between -9.04 kcal/mol to -7.32 kcal/mol, suggesting strong interactions. Non-bonded interactions of these compounds show favorable interactions with ATP7B protein. All the selected synthetic compounds name as D-Pencillamine, Tetrathimolybdate, and Trientine showed higher binding energies of -3.65 kcal/mol, -5.02 kcal/mol, and -7.20 kcal/mol. Conclusion: As compared to known synthetic drugs our findings revealed that Disogenin, Hecogenin, Berberine, and Anaferine, demonstrated the lowest binding energies with ATP7B protein. As we know that synthetic drugs have also adverse side effects as compare to natural drugs. These compounds can serve as potential therapeutic agents against Wilson's disease, offering a new avenue for the development of treatments targeting the mutated protein for molecular mechanisms of this devastating condition. Further experimental validation is warranted to confirm the efficacy and safety of these compounds in the context of Wilson disease therapy.

1 January 2024 in Eurasian Journal of Medical Advances
Verified
Journal Article
Closed access
MUMeenakshi Upadhyay
Meenakshi Upadhyay
SSSurbhi Singh
Surbhi Singh
SKSeema Khanna
Seema Khanna
SSSuchitra Singh
Suchitra Singh
RSRoyana Singh
Royana Singh
Objectives: This study aims to investigate the gene expression in breast cancer (BC) in response to radiation therapy using GEO2R analysis of datasets from the Gene Expression Omnibus database. Methods: The data used in the research was obtained from the GEO of the GSE 59732 and GSE 59734 gene expression datasets. These datasets included various breast cancer treated with radiation therapy. DEGs (Differentially expressed genes) were identified using GEO2R of p-value less than 0.05 and a log FC threshold of 1.2. STRING was used to generate PPI (protein-protein interaction) networks, while Cytoscape software was used to identify important hub genes. The Enrichr tool was used to analyze Gene Ontology and KEGG pathway and network analyst tool was used to study gene-disease association. Results: A total of 61 upregulated DEGs common in both datasets were observed in the study. Gene ontology analysis revealed that biological processes mostly enriched in regulation of peptidyl-tyrosin phosphorylation, cellular components mainly enriched in phosphatase binding. Proteoglycans in cancer found in both KEGG pathway and gene-disease association pathways. Conclusion: The study identified DEGs in breast cancer in response to radiation therapy. Key hub genes, particularly EGFR and MAPK3, were linked to many cancer-related pathways including breast cancer.